Immunitrack is a novel spin-out company from the University of Copenhagen that builds on more than a decade of research in the neonatal Fc receptor (FcRn) and Major Histocompablility Complex Molecules (MHC).

Immunitrack is currently embedded at BIO, in the Functional Genetics research section, and has enjoyed pre-seed financing from both Copenhagen Spin-outs in 2014 and Novo Nordisk Fund from 2015.

Link to Immunitrack home page